DK2323638T3 - Sammensætninger og fremgangsmåder til behandling af osteoartritis - Google Patents

Sammensætninger og fremgangsmåder til behandling af osteoartritis

Info

Publication number
DK2323638T3
DK2323638T3 DK09790642.4T DK09790642T DK2323638T3 DK 2323638 T3 DK2323638 T3 DK 2323638T3 DK 09790642 T DK09790642 T DK 09790642T DK 2323638 T3 DK2323638 T3 DK 2323638T3
Authority
DK
Denmark
Prior art keywords
procedures
compositions
treating osteoarthritis
osteoarthritis
treating
Prior art date
Application number
DK09790642.4T
Other languages
English (en)
Inventor
Ryan Michael Yamka
Nolan Zebulon Frantz
Xiangming Gao
Murrani Samer Al
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Application granted granted Critical
Publication of DK2323638T3 publication Critical patent/DK2323638T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK09790642.4T 2008-07-18 2009-07-20 Sammensætninger og fremgangsmåder til behandling af osteoartritis DK2323638T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8218508P 2008-07-18 2008-07-18
PCT/US2009/051169 WO2010009474A1 (en) 2008-07-18 2009-07-20 Compositions and methods for treating osteoarthritis

Publications (1)

Publication Number Publication Date
DK2323638T3 true DK2323638T3 (da) 2014-08-11

Family

ID=41059867

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09790642.4T DK2323638T3 (da) 2008-07-18 2009-07-20 Sammensætninger og fremgangsmåder til behandling af osteoartritis

Country Status (12)

Country Link
US (1) US9629382B2 (da)
EP (1) EP2323638B1 (da)
JP (2) JP2011528668A (da)
CN (1) CN102159197A (da)
AU (1) AU2009270718B2 (da)
BR (1) BRPI0915986A2 (da)
CA (1) CA2731067C (da)
DK (1) DK2323638T3 (da)
ES (1) ES2480193T3 (da)
RU (1) RU2619553C2 (da)
WO (1) WO2010009474A1 (da)
ZA (1) ZA201101055B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102159197A (zh) 2008-07-18 2011-08-17 希尔氏宠物营养品公司 治疗骨关节炎的组合物和方法
US20110159500A1 (en) * 2009-12-29 2011-06-30 Hill's Pet Nutrition, Inc. Compositions including ginger for the amelioration or prevention of inflammatory conditions
CN102138961A (zh) * 2010-02-02 2011-08-03 北京绿色金可生物技术股份有限公司 黑豆皮提取物在预防和治疗骨关节炎的产品中的应用
RU2525579C2 (ru) * 2010-05-12 2014-08-20 Хилл`С Пет Ньютришн, Инк. Способы контроля и профилактики воспаления и ослабления воспалительных состояний у животных компаньонов
BR112012028643A2 (pt) * 2010-05-12 2015-09-15 Hills Pet Nutrition Inc método para tratamento ou controle de uma condição inflamatória em um felino, e composição.
US10564169B2 (en) * 2010-05-12 2020-02-18 Colgate-Palmolive Company Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines
US20130263294A1 (en) * 2010-09-20 2013-10-03 Bioiberica, S.A. Markers for joint displasia, osteoarthritis and conditions secondary thereto
EP2704597B1 (en) * 2011-05-05 2021-04-07 Life Science Nutrition AS Performance enhancing compositions and methods of use
BR112014007947A2 (pt) * 2011-10-03 2017-04-18 Univ Los Andes método para monitoramento, diagnóstico e/ou prognóstico de distúrbios relacionados à hipoxia usando nfat5
RU2612901C2 (ru) 2011-12-19 2017-03-13 Хилл'С Пет Ньютришн, Инк. Композиции и способы диагностики и лечения гипертиреоза у животных-компаньонов
US20140220006A1 (en) * 2013-02-01 2014-08-07 Meso Scale Technologies, Llc Lung cancer biomarkers
CA3156908C (en) * 2015-01-06 2024-06-11 David Burton Mobile wearable monitoring systems
KR101972691B1 (ko) 2015-04-08 2019-04-25 마이크로바스쿨라 헬스 솔루션즈, 엘엘씨 상승적인 글리코칼릭스 치료 조성물 및 방법
EP3446127A4 (en) * 2016-04-20 2020-01-22 Crescendo Bioscience, Inc. BIOMARKERS AND METHODS FOR ASSESSING RESPONSE TO INFLAMMATORY DISEASE TREATMENT
WO2018124189A1 (ja) * 2016-12-28 2018-07-05 協和発酵キリン株式会社 細胞を選抜する方法
JP7136807B2 (ja) 2017-04-17 2022-09-13 ザ・ユニバーシティ・オブ・シカゴ ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料
CN107412240A (zh) * 2017-07-24 2017-12-01 冯纪敏 一种组合物及其应用
JP7030194B2 (ja) * 2017-11-17 2022-03-04 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド オメガ－３ポリ不飽和および中鎖脂肪酸を含む組成物
WO2019217973A1 (en) * 2018-05-11 2019-11-14 Rhode Island Hospital Compositions and methods for treating articulating joint disorders with nucleoside reverse transcriptase inhibitors
CN109266738A (zh) * 2018-11-19 2019-01-25 山西中医药大学 类风湿关节炎大鼠炎症因子检测引物及其方法
CN109680046B (zh) * 2019-01-17 2021-08-10 浙江大学 骨关节炎第一亚型的生物标记物以及用途
CN109965124A (zh) * 2019-03-29 2019-07-05 华熙生物科技股份有限公司 一种宠物食品及其制备方法
CN110511937B (zh) * 2019-08-05 2021-07-09 华南农业大学 Snf7基因及其防治瓢虫的应用
WO2021126159A1 (en) * 2019-12-16 2021-06-24 Hill's Pet Nutrition, Inc. Pet food compositions
US20240382518A1 (en) * 2021-09-17 2024-11-21 Seoul National University R&Db Foundation Pharmaceutical composition and health functional food for prevention or treatment of osteoarthritis

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0951909T4 (da) * 1998-03-19 2011-01-24 Sigma Tau Ind Farmaceuti Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU1704100A (en) * 1998-09-08 2000-03-27 Monsanto Company Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6277842B1 (en) * 2000-10-17 2001-08-21 James Alexander Carthron Dietary supplemental method for fat and weight reduction
US20020099032A1 (en) * 2000-11-10 2002-07-25 Kiyotsugu Higashi Preparations and method of producing the same
US20060240037A1 (en) * 2003-06-04 2006-10-26 Edward Fey Methods and compositions for the treatment and prevention of degenerative joint disorders
US8633246B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
BRPI0413287A (pt) * 2003-08-11 2006-10-10 Hills Pet Nutrition Inc métodos de restaurar uma função da articulação que é mais próxima do normal em um cão apresentando osteoartrite, e de eliminar a probabilidade de um cão desenvolver osteoartrite, e, uso de ácido eicosapentaenóico (epa)
US8377904B2 (en) * 2004-02-09 2013-02-19 Hill's Pet Nutrition, Inc. Composition and method for use in cartilage affecting conditions
RU2351153C2 (ru) * 2004-07-01 2009-04-10 Нестек С.А. Композиция диеты при остеоартрите собак
WO2006053010A2 (en) * 2004-11-09 2006-05-18 Hill's Pet Nutrition, Inc. Use of antioxidants for gene modulation
WO2007002837A2 (en) * 2005-06-29 2007-01-04 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatement of inflammatory disease
AU2006332614A1 (en) * 2005-12-28 2007-07-12 Hill's Pet Nutrition, Inc. Method of diagnosing a body weight condition or predisposition in an animal
US8021659B2 (en) * 2006-04-28 2011-09-20 Naidu Lp Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
CN102159197A (zh) 2008-07-18 2011-08-17 希尔氏宠物营养品公司 治疗骨关节炎的组合物和方法

Also Published As

Publication number Publication date
US20110183006A1 (en) 2011-07-28
CA2731067C (en) 2013-10-01
US9629382B2 (en) 2017-04-25
BRPI0915986A2 (pt) 2015-11-03
WO2010009474A1 (en) 2010-01-21
JP6047128B2 (ja) 2016-12-21
AU2009270718A1 (en) 2010-01-21
EP2323638B1 (en) 2014-05-07
CA2731067A1 (en) 2010-01-21
ES2480193T3 (es) 2014-07-25
AU2009270718B2 (en) 2012-09-06
RU2011106033A (ru) 2012-08-27
RU2619553C2 (ru) 2017-05-16
ZA201101055B (en) 2014-07-30
CN102159197A (zh) 2011-08-17
EP2323638A1 (en) 2011-05-25
JP2014237709A (ja) 2014-12-18
JP2011528668A (ja) 2011-11-24

Similar Documents

Publication Publication Date Title
DK2894165T5 (da) Fremgangsmåder og sammensætninger til behandling af komplementforbundne forstyrrelser
DK2470656T3 (da) Sammensætning til hæmning af genekspression og anvendelser heraf
DK2361090T3 (da) Sammensætninger til behandling af centralt medieret kvalme og opkastning
DK3181134T3 (da) Bifidobakterier til behandling af diabetes og relaterede tilstande
DK3128014T3 (da) Midler og fremgangsmåder til sterilisering af biofunktionelle sammensætninger
DK2252342T3 (da) Indretninger og fremgangsmåder til behandling af skadet væv
DK2061561T3 (da) Sammensætninger til behandling af cancer
DK2212070T3 (da) Fremgangsmåde til behandling af træ
DK2365988T4 (da) Tværbundne kationsbytningspolymerer, sammensætninger og anvendelse til behandling af hyperkaliæmi
DK2429574T3 (da) Sammensætninger og fremgangsmåder til behandling af hæmatologiske cancere der targeterer sirp-cd47-interaktionen
DK3795573T3 (da) Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf
DK2365802T3 (da) Mikrokapsler af rapamycin og anvendelse til behandling af cancer
DK2187880T3 (da) Sammensætninger og fremgangsmåder til behandling af makuladegeneration
DK2310034T3 (da) Peptider til behandling af beta-amyloidose
ZA201101055B (en) Compositions and methods for treating osteoarthritis
DK3272879T3 (da) Transposonendesammensætninger og fremgangsmåder til modificering af nukleinsyrer
DK2473034T3 (da) Frøbehandlingssammensætninger og fremgangsmåde
DK2293816T3 (da) Fremgangsmåder til behandling af reumatoid arthritis
DK3260118T3 (da) Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
DK3443957T3 (da) Forbindelser og sammensætninger til behandling af cancer
DK2398902T3 (da) Fremgangsmåder og sammensætninger til diagnosticering og behandling af cancer
DK2350116T3 (da) Behandling af biofilm
DK2270818T3 (da) Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten
DK2245032T3 (da) Folater, sammensætninger og anvendelser deraf
DK2099489T3 (da) Sammensætninger og fremgangsmåder til behandling af en neoplasme